TLR4-deficient MSCs displayed impaired capacity to inhibit Th1 and Th17 cell differentiation compared with WT MSCs, and thus lost their ability to ameliorate experimental autoimmune encephalomyelitis 19. The gene discussed is TLR4; the disease is experimental autoimmune encephalomyelitis.